Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Single Source Competition for Continuation of Understanding and Targeting the Pathophysiology of Youth-Onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed)

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The DISCOVERY study is a multi-center longitudinal effort involving 19 clinical sites dedicated to identifying risk factors and biological mechanisms underlying the development of type 2 diabetes in youth during early puberty. The study is actively recruiting and following high-risk participants over time to understand the progression of the disease, with the Biostatistics Research Center serving as the central coordinating hub responsible for protocol execution, data management, quality control, statistical analysis, and seamless coordination across all participating sites. The center has built a comprehensive infrastructure to ensure data integrity and consistency throughout the prolonged follow-up period. This solicitation seeks to continue support for the existing clinical consortium to achieve its scientific goals, focusing on advancing knowledge of youth-onset type 2 diabetes pathophysiology. The funding opportunity is issued by the National Institutes of Health under the Department of Health and Human Services through a single-source competition, with no set-aside designation. The opportunity is managed by the Division of Diabetes, Endocrinology and Metabolic Diseases, and all correspondence should be directed to niddk_dem@nih.gov. The forecast was posted on August 4, 2026, and no clinical trial is permitted under this award.

General Info

Continue support for youth type 2 diabetes research across 19 sites with centralized data coordination.

Agency

Department Of Health And Human Services → National Institutes Of HealthView Agency

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)View NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health
View Agency Profile
Office AddressUS
Contacts
Division of Diabetes Endocrinology and Metabolic Diseases

Full Description

Show more

The DISCOVERY of Risk Factors for Type 2 Diabetes in Youth Study is a multi-center longitudinal consortium conducted across 19 clinical sites to identify risk factors and biological mechanisms driving progression to youth-onset type 2 diabetes. The study is actively recruiting and following early pubertal youth at high risk for the disease with longitudinal follow-up currently underway. The current Biostatistics Research Center (BRC) serves as the consortium's central coordinating center, managing protocol implementation, data management, quality assurance, statistical design and analysis, and inter-site and consortium-wide coordination.  The BRC has established the robust infrastructure and standardized processes required to support the study and preserve the integrity of the longitudinal dataset. 

The purpose of this single-source solicitation is to support completion of the scientific objectives of the ongoing DISCOVERY clinical consortium.

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Federal
Evaluations, Assessments and Support Services (EASS)
Solicitation # RFI-EASS2026
NASA Langley Research Center is conducting market research through a Request for Information and Sources Sought notice to inform the upcoming procurement of the Evaluations, Assessments, and Support Services (EASS) contract, aiming to identify industry capabilities and foster competition, especially among small businesses, Historically Black Colleges and Universities, and Minority Institutions. The procurement, classified under NAICS code 541715 with a size standard of 1,000 employees, will support the Science Office for Mission Assessments by providing evaluations of proposal and Phase A reports in accordance with NASA guidelines, independent assessments of missions and programs using established NASA policies, and comprehensive support services including technical, managerial, cost, and schedule analyses. The government anticipates a single-award, indefinite-delivery, indefinite-quantity contract with both cost-plus-fixed-fee and firm-fixed-price task orders, and is actively seeking industry feedback on contract structure, commerciality, incentive alignment, and ways to streamline procurement processes. Respondents are required to submit capability statements not exceeding ten pages, detailing their organizational structure, size designation, past performance, technical expertise in evaluation and assessment functions, and their approach to managing organizational and personal conflicts of interest, with particular attention to the draft Data Requirements Document on OCI Plans. Firms must also confirm their ability to support work requiring access to Top Secret/Sensitive Compartmented Information, either through existing facility clearance or the capacity to obtain one with NASA sponsorship. Responses are due by August 5, 2026, and must be submitted electronically without export-controlled information; while submissions are voluntary and not compensated, they will inform NASA’s acquisition strategy, with proprietary information marked as confidential protected under the Freedom of Information Act.
NASA Langley Research Center

POSTED

about 6 hours ago

DEADLINE

in 3 days
View Details
NAICS: 541715
New
Grant
DoW Reconstructive Transplant, Investigator-Initiated Research AwardThe FY26 Reconstructive Transplant Research Program Investigator-Initiated Research Award supports innovative, scientifically rigorous studies aimed at advancing reconstructive transplant research and improving patient outcomes, particularly for military Service Members, Veterans, and their families. Proposals must demonstrate strong scientific rationale and direct military relevance, addressing healthcare needs arising from traumatic injuries, and are expected to contribute meaningfully to short- and long-term advances in the field. Eligible research spans the full spectrum from basic science and preclinical animal models to clinical studies involving human subjects or anatomical tissues, but explicitly excludes clinical trials as defined by federal guidelines. A robust study design with attention to reproducibility, including a statistically sound power analysis, is required to ensure the validity and translational potential of the proposed work. Applicants must include preliminary or published data that directly support the feasibility and relevance of the research to reconstructive transplantation, and projects must align with one or more of the designated FY26 RTRP Focus Areas. While collaboration with military researchers and clinicians is encouraged to enhance relevance and impact, it is not a mandatory requirement. The program is open to investigators across academic, medical, and research institutions who can demonstrate a clear pathway from laboratory findings to improved care and quality of life. Applications should emphasize the potential for broad impact both within the reconstructive transplant community and among the wider population of trauma survivors. All submissions must be made through the eBRAP system with inquiries directed to the designated point of contact.
Defense Health Agency Contracting Activity - Dhaca

POSTED

about 14 hours ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Federal
Data Analysis and Modeling for Integration VerificationThe contract pertains to data analysis, simulation, and modeling activities aimed at verifying the integration performance of complex systems, evaluating test outcomes, and enabling informed engineering decisions through the development and application of predictive models. The work requires advanced analytical capabilities to interpret large datasets, simulate system behaviors under varied conditions, and translate findings into actionable insights that support system validation and optimization. The contractor must deliver robust modeling frameworks capable of forecasting performance metrics, identifying anomalies, and contributing to the iterative refinement of engineering systems throughout their development lifecycle. This subcontract is issued under the NAICS code 541715, aligning with scientific research and development services, and is managed by the Department of Defense through the agency FA8219 Afnwc Pzbg. The opportunity was posted on August 3, 2026, with a response deadline of October 5, 2026. The place of performance is specified as a zip code of 19406, indicating the work will be conducted at or near that geographic location. While no set-aside provisions are indicated, the nature of the work implies a focus on technical expertise in modeling and simulation, requiring qualified entities with proven experience in defense-related integration verification and predictive analytics.
FA8219 Afnwc Pzbg

POSTED

1 day ago

DEADLINE

in 2 months
View Details
NAICS: 541715
New
Federal
ManTech special Broad Agency Announcement (sBAA): Accelerating Maritime Modernization: Innovation in Naval Manufacturing, Sustainment, and Industrial Base Capability
Solicitation # N0001426SB002
The Navy Manufacturing Technology Program is seeking innovative research and development proposals through solicitation N0001426SB002 to enhance shipbuilding and maintenance capabilities by improving speed, throughput, and industrial base resilience. The focus is on transforming shipyards, maintenance depots, and supply chain operations through breakthrough manufacturing technologies that enable faster construction, arming, and repair of naval vessels. Proposals must clearly demonstrate how they remove existing bottlenecks and strengthen the nation’s shipbuilding enterprise by increasing efficiency, adaptability, and competitiveness across the defense industrial base. This initiative is critical to sustaining and modernizing the U.S. naval industrial infrastructure to meet current and future operational demands. Proposals are due by September 16, 2026, and are open to organizations responding to the Small Business Administration Assistance program under NAICS code 541715. The solicitation is managed by the Office of Naval Research in Arlington, Virginia, with primary point of contact Stephanie L. Marsh and secondary contact Miranda Fleck for inquiries. Performance locations are not specified, allowing flexibility for applicants to propose solutions that can be implemented across various U.S. naval manufacturing and maintenance facilities. Interested parties must submit their responses via the SAM.gov portal before the deadline to be considered for funding and collaboration opportunities aimed at revolutionizing naval manufacturing.
Office Of Naval Research

POSTED

1 day ago

DEADLINE

in about 1 month
View Details
NAICS: 541715
New
Federal
Army Contracting Command – Red River Army Depot (ACC-RRAD) Organic Industrial Base (OIB) Modernization Commercial Solutions Opening (CSO)
Solicitation # W911RQ-26-S-C001
The U.S. Army, through the Army Contracting Command – Red River Army Depot, is pursuing the modernization of its Organic Industrial Base under Commercial Solutions Opening W911RQ-26-S-C001, a flexible procurement initiative authorized under DFARS Subpart 212.70 and administered under FAR Part 12 Commercial Item Procedures. This effort is aligned with the Army’s strategic focus on Convergent Manufacturing, integrating advanced technologies such as digital twin, automation, connected digital enterprise, and cybersecurity to enhance producibility, sustainment, and logistics capabilities. The solicitation invites innovative commercial solutions across multiple areas of interest including automated media blast systems, camera monitoring for vehicle test tracks, power pack interface and test sets, AS9100 certification support, track pin and bushing manufacturing, and fixture removal for Bradley Fighting Vehicle hulls. Each area of interest is evaluated independently with specific submission deadlines, and all responses must be submitted electronically via email in two separate volumes: a technical proposal excluding cost data and a price proposal with full cost breakdowns, including labor rates, material quotes, and overhead. Offers must be unclassified, submitted through SAM.gov-registered entities with a Unique Entity ID, and adhere to strict formatting rules including a maximum of five pages or fifteen slides for initial solution briefs. Evaluation of proposals prioritizes technical merit and feasibility, followed by industrial base impact, speed and scalability of implementation, price fairness and reasonableness, private investment leverage, and a credible transition plan to full production. The government will use a trade-off approach rather than lowest price technically acceptable, with no numerical weights assigned but clear emphasis on non-price factors. Awards are contingent upon funding availability, successful negotiation, and technical validation, and do not obligate the government to proceed with any contract until formal award. Performance is expected to occur at Red River Army Depot in Texarkana, Texas, with inspection and acceptance conducted by the government at that location per MIL-DTL-11891, MIL-STD-1907, ASTM, and other referenced standards covering material quality, inspection, and manufacturing processes. Contractors must register in Wide Area Work Flow for invoicing, and proposals must comply with secure-by-design principles and modular open systems architecture requirements. No contract clauses, special requirements, or detailed packaging and marking specifications are provided in the solicitation, leaving these to be defined during contract negotiation post-selection. All submissions must be received by 5:00 P.M. CDT on their respective
W6QK Acc Rrad

POSTED

1 day ago

DEADLINE

in about 2 months
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health

Same awarding agency

NAICS: 541715
New
Grant
Investigator-Focused Award (Parent R35)The National Institutes of Health is preparing to release a Parent R35 Investigator-Focused Award opportunity to support researchers at all career stages, including Early Stage Investigators, through a funding mechanism designed to sustain an entire program of research aligned with the mission of the awarding Institute or Center. Unlike traditional grants that fund specific projects with defined aims, the R35 provides broad, long-term support for an investigator’s scientific vision, enabling them to pursue high-risk, high-reward research without being constrained by narrow project boundaries. This award is intended to be the primary or sole source of research funding from the NIH for the recipient, offering financial stability and the freedom to adapt research directions as new opportunities emerge. The R35 award emphasizes scientific autonomy and reduced administrative burden, allowing recipients to focus more on research, mentoring, and scientific service rather than grant writing and compliance. Key advantages include the ability to follow emerging scientific leads, tackle complex and challenging questions, and foster breakthrough discoveries by encouraging broad, innovative thinking. The award is not restricted by predefined goals, giving investigators maximum flexibility to evolve their research programs over time. The solicitation is published as a forecast with a posted date of July 30, 2026, and all correspondence and inquiries should be directed to the Office of Extramural Research at parentr35@mail.nih.gov.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

6 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed)The NIH INCLUDE Project is soliciting applications to contribute biospecimens from individuals with Down syndrome and control populations for comprehensive genomic and multi-omics analysis, aiming to uncover the molecular underpinnings of health conditions associated with Down syndrome. This initiative does not provide direct funding to applicants but encourages the submission of existing samples to generate large-scale, integrated data that will be deposited into the INCLUDE Data Hub, making it accessible to the broader scientific community to accelerate research. The focus is on omics phenotypes, with an emphasis on maximizing the scientific value of already collected biospecimens rather than collecting new ones. The opportunity is open to researchers who can align with the goal of generating high-quality, shared data resources and is not eligible for clinical trials. All data generated, including clinical and phenotypic information, will become part of a centralized repository to support collaborative discovery. The notice was posted by the National Institutes of Health under the Department of Health and Human Services, with inquiries directed to the INCLUDE Project email address, and the solicitation is available through the Grants.gov platform. Participation is contingent on the ability to deliver samples and associated metadata to designated NIH-supported resources.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

8 days ago

DEADLINE

N/A
View Details
NAICS: 541512
Grant
Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)The National Institutes of Health, through the National Cancer Institute, is preparing to issue a funding opportunity aimed at advancing and sustaining high-impact informatics technologies critical to cancer research. This initiative supports tools and software that have moved beyond early-stage prototypes and demonstrate clear potential for broad application across the cancer research continuum, including cancer biology, diagnosis, treatment, early detection, risk assessment, prevention, control, and epidemiology. The program focuses on enhancing, optimizing, and disseminating existing technologies to ensure their long-term usability and adoption by the broader scientific community, with an emphasis on capabilities in data acquisition, management, analysis, visualization, and interpretation. This funding opportunity, designated as U24 and labeled as clinical trial optional, is part of the NCI’s Informatics Technology for Cancer Research Program and is open to organizations capable of scaling proven informatics resources. While no set-aside categories or NAICS codes are specified, interested applicants should note the official point of contact for inquiries is the ITCR Mailbox, reachable via email or phone. The forecasted posting date is July 28, 2026, and all details can be accessed through the Grants.gov portal. The program seeks to ensure that critical digital infrastructure remains robust, adaptable, and accessible to accelerate discoveries and improve outcomes in cancer research.
Computer Systems Design Services

POSTED

8 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Limited Competition: Institutional Mentored Research Career Development Program for the Clinical and Translational Science Awards ProgramThe National Institutes of Health is forecasting a limited competition for the Institutional Mentored Research Career Development Program under the Clinical and Translational Science Awards Program, aimed at advancing the careers of later-stage postdoctoral fellows and junior faculty dedicated to independent research in clinical and translational science. The program seeks to establish institutional frameworks that provide structured mentoring, training, and research support to ensure timely progression and long-term engagement in transformative health research that bridges laboratory discoveries with real-world patient and public health outcomes. Funding is authorized under Sections 301 and 405 of the Public Health Service Act and governed by federal regulations including 42 CFR Part 52 and 2 CFR Part 200. Only eligible organizations may apply, and submissions will undergo standard NIH peer review, with awards granted exclusively to meritorious proposals. This funding opportunity is part of the broader Congressionally mandated CTSA initiative designed to build a nationwide network of academic medical centers equipped to accelerate the translation of scientific innovation into clinical and community health improvements. The forecast was posted on July 20, 2026, and inquiries should be directed to the Division of Clinical Innovation at NCATS via the designated email address. All applications must comply with NIH guidelines and are subject to the terms of a limited competition, with no public solicitation beyond the eligible pool of institutions.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

16 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant for the Clinical and Translational Science Awards ProgramThe National Institutes of Health, under the Department of Health and Human Services, is forecasting a limited competition for the Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant aimed at advancing clinical and translational science. This initiative supports accredited academic medical centers in developing comprehensive training programs for predoctoral and postdoctoral researchers, equipping them with the skills and infrastructure necessary to translate scientific discoveries into effective patient care and public health interventions. The program is aligned with the broader Congressionally mandated Clinical and Translational Science Award (CTSA) initiative, which fosters a national network of institutions dedicated to accelerating the movement of research from laboratory to clinic and community. Funding is authorized under Sections 301 and 405 of the Public Health Service Act and governed by federal regulations including 42 CFR Part 52 and 2 CFR Part 200. Only eligible organizations invited through the limited competition may submit applications, which will undergo standard NIH peer review to determine merit and funding eligibility. The opportunity is managed by the Division of Clinical Innovation at the National Center for Advancing Translational Sciences, with inquiries directed to a designated point of contact. The forecast was posted on July 20, 2026, and interested parties are encouraged to review eligibility criteria and application guidelines through the official Grants.gov portal.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

16 days ago

DEADLINE

N/A
View Details
NAICS: 923120
Grant
Limited Competition: Research Education Program for the Clinical and Translational Science Awards ProgramThe Congressionally mandated Clinical and Translational Science Award Program aims to accelerate the translation of scientific discoveries into practical treatments, diagnostics, and health interventions that enhance patient and public health by establishing a national network of academic medical centers equipped with the infrastructure, expertise, training, and collaborative frameworks necessary to bridge laboratory research with clinical and community practice. This forecasted limited competition seeks to support research education activities that complement and strengthen the training of a skilled workforce capable of addressing the nation’s demands in biomedical, behavioral, and clinical research, aligning with the broader goals of the CTSA Program. Awards will be issued under the authority of Sections 301 and 405 of the Public Health Service Act as amended and governed by Federal Regulations 42 CFR Part 52 and 2 CFR Part 200. Only eligible organizations may apply, and submissions will undergo the National Institutes of Health’s standard peer-review process, with funding reserved for the most meritorious proposals. The opportunity is open to a restricted pool of applicants as defined in the eligibility criteria, with applications to be submitted through the official grants portal, and inquiries should be directed to the Division of Clinical Innovation at NCATS.
Administration of Public Health Programs

POSTED

16 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational ScienceThe Congressionally mandated Clinical and Translational Science Award Program aims to accelerate the translation of scientific discoveries into practical health solutions by funding a national network of academic medical centers that provide the infrastructure, expertise, training, and collaborative environment necessary to move research from the laboratory into clinical practice and community health. Within this program, the High Impact Specialized Innovation Programs are designed to support unique, high-value capabilities, research platforms, or resources that address critical gaps or persistent roadblocks in clinical and translational science at designated CTSA hubs. These initiatives are intended to deliver timely, transformative advances that enhance the overall efficiency and impact of the CTSA network. Awards under this forecast are authorized under Sections 301 and 405 of the Public Health Service Act and governed by federal regulations including 42 CFR Part 52 and 2 CFR Part 200. This is a limited competition forecast, meaning only pre-eligible organizations may apply, and applications will undergo NIH’s standard peer-review process. Only those deemed meritorious will be considered for funding. The National Institutes of Health, through the Department of Health and Human Services and the Division of Clinical Innovation at NCATS, is soliciting applications with a forecast date of July 20, 2026, and inquiries should be directed to the provided point of contact.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

16 days ago

DEADLINE

N/A
View Details
NAICS: 923120
Grant
Clinical and Translational Science AwardThe Congressionally mandated Clinical and Translational Science Award (CTSA) Program aims to strengthen the national infrastructure for accelerating the translation of scientific discoveries into practical treatments, diagnostics, and health interventions that enhance patient and public health. This initiative funds a network of academic medical centers to provide the essential resources, expertise, training, and collaborative frameworks needed to bridge the gap between laboratory research and clinical practice, as well as community health implementation. The reissuance of the Notice of Funding Opportunity is designed to support a comprehensive CTSA Hub that fosters an integrated environment for research and training in clinical and translational science, while promoting the development, testing, and broad adoption of innovative methods and technologies that increase the efficiency and quality of the entire translational research pipeline. Funding for this program is authorized under Sections 301 and 405 of the Public Health Service Act, as amended, and is governed by federal regulations including 42 CFR Part 52 and 2 CFR Part 200. The National Institutes of Health, within the Department of Health and Human Services, has issued this forecast to invite eligible organizations to submit applications. Proposals will undergo the NIH’s standard peer-review process, with funding awarded only to those deemed meritorious. The point of contact for inquiries is the Division of Clinical Innovation at NCATS, reachable via the provided email, and all applications must be submitted through the official grants portal listed in the posting.
Administration of Public Health Programs

POSTED

16 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
The Next Generation of the Clinical and Translational Science Awards Program Trial Innovation NetworkThe Next Generation of the Clinical and Translational Science Awards Program Trial Innovation Network is a forecasted funding opportunity issued by the National Institutes of Health under the Department of Health and Human Services to accelerate the development and execution of multi-center clinical trials. The initiative aims to overcome systemic barriers in trial design and implementation by fostering innovation in areas such as safety monitoring, digital health technologies, genomic capacity, disease progression modeling, and leadership training. It seeks to establish a national platform for advancing the science of clinical research through scalable, efficient, and cost-effective solutions, positioning the network as both a practical engine for trial delivery and a laboratory for methodological discovery. Applications must be submitted by eligible organizations and will be evaluated through the NIH’s standard peer-review process, with funding decisions based on merit and potential impact. The opportunity is authorized under Sections 301 and 405 of the Public Health Service Act and governed by Federal Regulations 42 CFR Part 52 and 2 CFR Part 200. While no specific set-aside or NAICS code has been designated, the announcement is open to all qualified applicants who meet the eligibility criteria outlined in the full notice. The forecast was posted on July 20, 2026, and point of contact for inquiries is the Division of Clinical Innovation at NCATS, reachable via tin@nih.gov. Further details and application guidance are available through the Grants.gov portal using the provided UI link, and submissions will follow the NIH’s standard review and selection protocols.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

16 days ago

DEADLINE

N/A
View Details
NAICS: 541714
Grant
Limited Competition: Clinical and Translational Science Awards (CTSA) Program: Collaborative and Innovative Acceleration AwardThe Congressionally mandated Clinical and Translational Science Awards (CTSA) Program aims to accelerate the translation of scientific discoveries into practical treatments, diagnostics, and health interventions that enhance patient and public health by funding a national network of academic medical centers. This network provides essential infrastructure, expertise, training, and collaborative platforms needed to move research from the laboratory into clinical practice and community health settings. The current opportunity is a forecast for a limited competition soliciting applications for the Collaborative and Innovative Acceleration Award, designed to support the development and implementation of novel approaches, technologies, or models that amplify the impact of translational research and expedite the delivery of effective therapies to all populations. Funding is authorized under Sections 301 and 405 of the Public Health Service Act, and governed by Federal Regulations 42 CFR Part 52 and 2 CFR Part 200. Eligible organizations may apply under this limited competition, and proposals will undergo standard National Institutes of Health peer review, with funding awarded only to meritorious applications. The announcement is issued by the National Institutes of Health, under the Department of Health and Human Services, with specific inquiries directed to the Division of Clinical Innovation at NCATS. The forecast was posted on July 20, 2026, and further details can be accessed through the official grants.gov listing, though no set-aside type, NAICS code, or specific place of performance is indicated.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

16 days ago

DEADLINE

N/A
View Details
NAICS: 541714
Grant
Elucidation and Validation of the role of Transporters in the Placenta, Lactating Mammary Gland, Developing Gut, and Blood Brain BarrierThe Eunice Kennedy Shriver National Institute of Child Health and Human Development is advancing its mission to improve maternal, fetal, and child health by launching a second phase of the Transporter Elucidation Network, focused on understanding how biological transporters and local metabolic processes regulate exposure to nutrients, medications, microbiome-derived compounds, and environmental chemicals across critical perinatal barriers. This initiative will develop comprehensive multi-barrier frameworks that connect the maternal gut, placenta, lactating mammary epithelium, infant gut, and infant blood-brain barrier, building on prior organ-specific research to create standardized models, resources, and prototype multi-compartment systems that reflect the dynamic interplay of transporters, their polarity, kinetics, and biotransformation capacities during pregnancy, lactation, and infant development. The goal is to deepen mechanistic insights into how these systems influence nutrient delivery, drug distribution, and neurodevelopmental outcomes in early life. This phase will establish community-wide resources to support integrated studies of perinatal exposure, risk assessment, and targeted interventions across linked maternal-fetal-infant systems, while strengthening collaboration among researchers and accelerating the sharing of tools and data. Emphasis is placed on human-based and developmentally relevant models to ensure biological accuracy and translational impact. The effort also aims to cultivate a next-generation workforce skilled in transporter science, fostering innovation in pediatric pharmacology and neonatal health. Authorized under 42 U.S.C. § 241, the initiative is being led by the Obstetric and Pediatric Pharmacology and Therapeutics Branch of NICHD, with inquiries directed to their designated point of contact, and the opportunity was publicly forecasted on July 16, 2026.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

20 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Opportunities for Collaborative Research with the NIH Intramural Research Program (U01 Clinical Trial Optional)The program aims to foster collaborative translational research between NIH intramural scientists and external extramural investigators to accelerate the translation of basic biological discoveries into clinical applications that improve health. It supports high-quality science with the potential to advance understanding of significant disease processes or lead to new diagnostics, therapeutics, or prevention strategies aligned with the priorities of participating NIH Institutes and Centers. The initiative specifically encourages partnerships that leverage the unique resources and expertise available within the NIH intramural research program, enabling extramural researchers to conduct clinical research in collaboration with NIH scientists. This effort is designed to strengthen translational science by bridging the gap between laboratory-based research and clinical implementation through integrated, multidisciplinary teams. The funding opportunity, titled Opportunities for Collaborative Research with the NIH Intramural Research Program (U01 Clinical Trial Optional), is posted by the National Institutes of Health under the Department of Health and Human Services and is forecasted for release on July 16, 2026. It is open to both intramural and extramural investigators and allows for clinical trials as optional components. The primary point of contact for inquiries is the U01 Program team, reachable via email at nihirppartnerships@mail.nih.gov or by phone at 301-496-4121. Additional details and application information can be accessed through the Grants.gov portal at the provided link. The program does not specify a set-aside type, NAICS code, or physical office location, reflecting its national scope and administrative structure under NIH's broader research framework.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

20 days ago

DEADLINE

N/A
View Details